The UK has been working to establish a life sciences hub for biotech R&D, with new funds for start-ups, pledging to speed its approval process, and courting some major players to expand in the country. Sciformix aims to take advantage of this and play a role in this growth.
Manish Soman, president and chief executive officer of Sciformix said, “Sciformix’s long term strategy focuses on evolving and enhancing our service and technology offerings, broadening our global reach and growing and diversifying the client and revenue base. Building a European hub will support all of these objectives. With our clients’ growth in emerging markets, it has become increasingly important for us to truly understand the local safety and regulatory challenges our clients face and to become the partner of choice when it comes to outsourcing these activities. Sciformix is such a trusted provider.”